American Kidney Fund’s Local Programs Supporting Living Kidney Donors Combine to Form New Living Donor Assistance Program
January 14, 2025 12:07 ET
|
American Kidney Fund
ROCKVILLE, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) announced the consolidation of two vital initiatives—the David Atkins Fund and the living kidney donor program...
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
January 13, 2025 07:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
American Kidney Fund Appoints Dr. Pranav Garimella as its First Chief Medical Officer
January 08, 2025 09:01 ET
|
American Kidney Fund
ROCKVILLE, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund today announced Dr. Pranav Garimella as its Chief Medical Officer (CMO). A nationally recognized leader in nephrology and...
Renown Health Officially Opens Life-Saving Kidney Transplant Program
December 18, 2024 18:08 ET
|
Renown Health
Reno, NEV., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Renown Health announced the official opening today of the Renown Transplant Institute, a multidisciplinary team of leading surgeons, physicians, and...
Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms
December 02, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with Oncocyte’s assay significantly reduces time to...
American Kidney Fund’s Second Patient Access Initiative Summit Will Highlight Health Care Challenges Faced by Kidney Community, Outline Public Policy Solutions
November 19, 2024 09:18 ET
|
American Kidney Fund
ROCKVILLE, Md., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) will host its second Patient Access Initiative (PAI) Summit—part of AKF’s ongoing work to address health care...
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
November 12, 2024 16:01 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
November 06, 2024 16:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
Memo Therapeutics AG Appoints Frits van Alphen, MD as Chief Development Officer
November 04, 2024 07:00 ET
|
Memo Therapeutics AG
PRESS RELEASE Frits is an industry veteran with a proven track record in nephrology drug development, including the successful development of Velphoro® and Ferinject® at Vifor Pharma Schlieren /...
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
October 29, 2024 07:46 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants